XML 145 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
No Par, Common Stock
Accumulated deficit
Accumulated Other Comprehensive Income (Loss)
Private placement
Private placement
No Par, Common Stock
Balance at beginning of period (in shares) at Dec. 31, 2016   7,633,070        
Balance at beginning of period at Dec. 31, 2016 $ 67,794 $ 80,342 $ (11,468) $ (1,080)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (2,866)   (2,866)      
Restricted stock unit expense, net (in shares)   (1)        
Restricted stock unit expense, net 466 $ 466        
Other comprehensive income (loss) 573     573    
Plus: cumulative effect of adoption of ASU No. 2018-02, net of taxes       0    
Balance at end of period (in shares) at Jun. 30, 2017   7,633,069.000        
Balance at end of period at Jun. 30, 2017 65,967 $ 80,808 (14,334) (507)    
Balance at beginning of period at Mar. 31, 2017       (746)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (1,067)          
Other comprehensive income (loss) 239          
Plus: cumulative effect of adoption of ASU No. 2018-02, net of taxes       0    
Balance at end of period (in shares) at Jun. 30, 2017   7,633,069.000        
Balance at end of period at Jun. 30, 2017 65,967 $ 80,808 (14,334) (507)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (18,676)   (18,676)      
Restricted stock unit expense, net (in shares)   87,259        
Restricted stock unit expense, net 429 $ 429        
Other comprehensive income (loss) 144     144    
Issuance of common stock in private placement (in shares)           800,000
Issuance of common stock in private placement         $ 5,000 $ 5,000
Common stock issuance costs (38) $ (38)        
Balance at end of period (in shares) at Dec. 31, 2017   8,520,328.000        
Balance at end of period at Dec. 31, 2017 52,826 $ 86,199 (33,010) (363)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Cumulative effect of adoption of ASU No. 2016-01, net of taxes 0   556 (556)    
Plus: cumulative effect of adoption of ASU No. 2018-02, net of taxes       77    
Balance at end of period at Mar. 31, 2018       (2,688)    
Balance at beginning of period (in shares) at Dec. 31, 2017   8,520,328.000        
Balance at beginning of period at Dec. 31, 2017 52,826 $ 86,199 (33,010) (363)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (900)          
Restricted stock unit expense, net 460 $ 460        
Other comprehensive income (loss) (2,218)          
Plus: cumulative effect of adoption of ASU No. 2018-02, net of taxes 0   77 77    
Balance at end of period (in shares) at Jun. 30, 2018   8,520,328        
Balance at end of period at Jun. 30, 2018 50,168 $ 86,659 (33,431) (3,060)    
Balance at beginning of period at Mar. 31, 2018       (2,688)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (1,113)          
Other comprehensive income (loss) (372)          
Plus: cumulative effect of adoption of ASU No. 2018-02, net of taxes       0    
Balance at end of period (in shares) at Jun. 30, 2018   8,520,328        
Balance at end of period at Jun. 30, 2018 $ 50,168 $ 86,659 $ (33,431) $ (3,060)